世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

口腔液と唾液による薬物検査の世界市場成長 2024-2030


Global Oral Fluid and Saliva Drug Testing Market Growth 2024-2030

口腔液および唾液薬物検査は、人の唾液中の薬物またはその代謝物の存在を検出するために使用される方法である。これらの検査は、非侵襲的な性質と投与の容易さから、職場、法執行機関、臨床環境など様々な環境で... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2024年7月24日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
183 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

口腔液および唾液薬物検査は、人の唾液中の薬物またはその代謝物の存在を検出するために使用される方法である。これらの検査は、非侵襲的な性質と投与の容易さから、職場、法執行機関、臨床環境など様々な環境で一般的に使用されています。
世界の口腔液・唾液薬物検査市場規模は、2024年の100万米ドルから2030年には100万米ドルに成長すると予測され、2024年から2030年までの年平均成長率は%で推移すると予測されています。
LPインフォメーション株式会社(東京都港区、代表取締役:劉克振)の最新調査レポート「経口液と唾液による薬物検査産業の予測」は、過去の売上高と2023年の経口液と唾液による薬物検査の世界総売上高に注目し、2024年から2030年に予測される経口液と唾液による薬物検査の売上高を地域別・市場分野別に包括的に分析しています。経口液および唾液薬物検査の売上高を地域別、市場分野別、サブセクター別に分類し、世界の経口液および唾液薬物検査産業の詳細な分析を百万米ドル単位で提供します。
このインサイトレポートでは、世界の経口液・唾液薬物検査業界を包括的に分析し、製品区分、企業形成、収益、市場シェア、最新動向、M&A活動に関する主要動向を明らかにします。また、本レポートでは、加速する世界の経口液・唾液薬物検査市場におけるこれらの企業の独自のポジションをよりよく理解するために、経口液・唾液薬物検査のポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析しています。
本インサイトレポートでは、経口液・唾液薬物検査の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの定性的・定量的市場インプットに基づいた透明性の高い手法により、この調査予測は世界の経口液・唾液薬物検査の現状と将来の軌道について非常にニュアンスのある見解を提供します。
経口液・唾液薬物検査の米国市場は、2023年の100万米ドルから2030年までに100万米ドルに増加し、2024年から2030年までの年平均成長率は%と推定される。
経口液・唾液薬物検査の中国市場は、2023年の100万米ドルから2030年には100万米ドルに、2024年から2030年までの年平均成長率は%で増加すると推定される。
経口液・唾液薬物検査のヨーロッパ市場は、2023年の100万米ドルから2030年には100万米ドルに、2024年から2030年までの年平均成長率は%で増加すると推定される。
経口液および唾液薬物検査の世界の主要企業は、Abbott、Premier Biotech、OraSure Technologies、MHE、VeriCheckなどです。売上高では、世界の2大企業が2023年にほぼ%のシェアを占めている。
のシェアを占めています。
本レポートでは、製品タイプ別、用途別、主要メーカー別、主要地域別および国別の口腔液および唾液薬物検査市場の包括的な概要、市場シェア、成長機会を紹介します。
タイプ別セグメント
5パネル以下
5パネル-10パネル
10パネル以上
用途別セグメント
刑事司法検査
職場検査
リハビリ療法
スポーツ競技
その他
本レポートはまた、市場を地域別に分けています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
アボット
プレミアバイオテック
オラシュア・テクノロジーズ
MHE
ベリチェック
ウルチメッド・プロダクツ(ドイツ)
ヒールゲン・サイエンティフィック
アルコライザー
ケアヘルスアメリカ
アルファバイオラボ
アルコデジタル
アゾバ
ドラッガー
Securetec Detektions-Systeme
クエスト・ダイアグノスティックス
オラノクシス
サリメトリクス
ネオジェン・コーポレーション
UCPバイオサイエンス
林志国際
メダックス
メディナット
WHPM
アキュバイオテック
アシュアテック
ウェルバイオテック
本レポートで扱う主な質問
世界の経口液および唾液薬物検査市場の10年展望は?
世界および地域別に、どのような要因が口腔液および唾液薬物検査市場の成長を促進しているのか?
市場別、地域別に最も急成長する技術は何か?
内服液および唾液薬物検査の市場機会は最終市場規模によってどのように異なるのか?
経口液および唾液薬物検査のタイプ別、用途別の内訳は?



ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oral Fluid and Saliva Drug Testing by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oral Fluid and Saliva Drug Testing by Country/Region, 2019, 2023 & 2030
2.2 Oral Fluid and Saliva Drug Testing Segment by Type
2.2.1 5 Panels or Less
2.2.2 5 Panel-10 Panel
2.2.3 10 Panels or Above
2.3 Oral Fluid and Saliva Drug Testing Sales by Type
2.3.1 Global Oral Fluid and Saliva Drug Testing Sales Market Share by Type (2019-2024)
2.3.2 Global Oral Fluid and Saliva Drug Testing Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Type (2019-2024)
2.4 Oral Fluid and Saliva Drug Testing Segment by Application
2.4.1 Criminal Justice Testing
2.4.2 Workplace Testing
2.4.3 Rehabilitation Therapy
2.4.4 Sports Competition
2.4.5 Others
2.5 Oral Fluid and Saliva Drug Testing Sales by Application
2.5.1 Global Oral Fluid and Saliva Drug Testing Sale Market Share by Application (2019-2024)
2.5.2 Global Oral Fluid and Saliva Drug Testing Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Oral Fluid and Saliva Drug Testing Breakdown Data by Company
3.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Company (2019-2024)
3.1.2 Global Oral Fluid and Saliva Drug Testing Sales Market Share by Company (2019-2024)
3.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Company (2019-2024)
3.2.1 Global Oral Fluid and Saliva Drug Testing Revenue by Company (2019-2024)
3.2.2 Global Oral Fluid and Saliva Drug Testing Revenue Market Share by Company (2019-2024)
3.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Company
3.4 Key Manufacturers Oral Fluid and Saliva Drug Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Fluid and Saliva Drug Testing Product Location Distribution
3.4.2 Players Oral Fluid and Saliva Drug Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Oral Fluid and Saliva Drug Testing by Geographic Region
4.1 World Historic Oral Fluid and Saliva Drug Testing Market Size by Geographic Region (2019-2024)
4.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oral Fluid and Saliva Drug Testing Market Size by Country/Region (2019-2024)
4.2.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oral Fluid and Saliva Drug Testing Sales Growth
4.4 APAC Oral Fluid and Saliva Drug Testing Sales Growth
4.5 Europe Oral Fluid and Saliva Drug Testing Sales Growth
4.6 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales Growth
5 Americas
5.1 Americas Oral Fluid and Saliva Drug Testing Sales by Country
5.1.1 Americas Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024)
5.1.2 Americas Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024)
5.2 Americas Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024)
5.3 Americas Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Fluid and Saliva Drug Testing Sales by Region
6.1.1 APAC Oral Fluid and Saliva Drug Testing Sales by Region (2019-2024)
6.1.2 APAC Oral Fluid and Saliva Drug Testing Revenue by Region (2019-2024)
6.2 APAC Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024)
6.3 APAC Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Fluid and Saliva Drug Testing by Country
7.1.1 Europe Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024)
7.1.2 Europe Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024)
7.2 Europe Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024)
7.3 Europe Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Fluid and Saliva Drug Testing by Country
8.1.1 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024)
8.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024)
8.3 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Fluid and Saliva Drug Testing
10.3 Manufacturing Process Analysis of Oral Fluid and Saliva Drug Testing
10.4 Industry Chain Structure of Oral Fluid and Saliva Drug Testing
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Fluid and Saliva Drug Testing Distributors
11.3 Oral Fluid and Saliva Drug Testing Customer
12 World Forecast Review for Oral Fluid and Saliva Drug Testing by Geographic Region
12.1 Global Oral Fluid and Saliva Drug Testing Market Size Forecast by Region
12.1.1 Global Oral Fluid and Saliva Drug Testing Forecast by Region (2025-2030)
12.1.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Oral Fluid and Saliva Drug Testing Forecast by Type (2025-2030)
12.7 Global Oral Fluid and Saliva Drug Testing Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.1.3 Abbott Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Premier Biotech
13.2.1 Premier Biotech Company Information
13.2.2 Premier Biotech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.2.3 Premier Biotech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Premier Biotech Main Business Overview
13.2.5 Premier Biotech Latest Developments
13.3 OraSure Technologies
13.3.1 OraSure Technologies Company Information
13.3.2 OraSure Technologies Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.3.3 OraSure Technologies Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 OraSure Technologies Main Business Overview
13.3.5 OraSure Technologies Latest Developments
13.4 MHE
13.4.1 MHE Company Information
13.4.2 MHE Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.4.3 MHE Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 MHE Main Business Overview
13.4.5 MHE Latest Developments
13.5 VeriCheck
13.5.1 VeriCheck Company Information
13.5.2 VeriCheck Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.5.3 VeriCheck Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 VeriCheck Main Business Overview
13.5.5 VeriCheck Latest Developments
13.6 ulti med Products (Deutschland)
13.6.1 ulti med Products (Deutschland) Company Information
13.6.2 ulti med Products (Deutschland) Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.6.3 ulti med Products (Deutschland) Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 ulti med Products (Deutschland) Main Business Overview
13.6.5 ulti med Products (Deutschland) Latest Developments
13.7 Healgen Scientific
13.7.1 Healgen Scientific Company Information
13.7.2 Healgen Scientific Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.7.3 Healgen Scientific Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Healgen Scientific Main Business Overview
13.7.5 Healgen Scientific Latest Developments
13.8 Alcolizer
13.8.1 Alcolizer Company Information
13.8.2 Alcolizer Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.8.3 Alcolizer Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Alcolizer Main Business Overview
13.8.5 Alcolizer Latest Developments
13.9 CareHealth America
13.9.1 CareHealth America Company Information
13.9.2 CareHealth America Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.9.3 CareHealth America Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 CareHealth America Main Business Overview
13.9.5 CareHealth America Latest Developments
13.10 AlphaBiolabs
13.10.1 AlphaBiolabs Company Information
13.10.2 AlphaBiolabs Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.10.3 AlphaBiolabs Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 AlphaBiolabs Main Business Overview
13.10.5 AlphaBiolabs Latest Developments
13.11 AlcoDigital
13.11.1 AlcoDigital Company Information
13.11.2 AlcoDigital Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.11.3 AlcoDigital Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 AlcoDigital Main Business Overview
13.11.5 AlcoDigital Latest Developments
13.12 Azova
13.12.1 Azova Company Information
13.12.2 Azova Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.12.3 Azova Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Azova Main Business Overview
13.12.5 Azova Latest Developments
13.13 Draeger
13.13.1 Draeger Company Information
13.13.2 Draeger Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.13.3 Draeger Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Draeger Main Business Overview
13.13.5 Draeger Latest Developments
13.14 Securetec Detektions-Systeme
13.14.1 Securetec Detektions-Systeme Company Information
13.14.2 Securetec Detektions-Systeme Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.14.3 Securetec Detektions-Systeme Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Securetec Detektions-Systeme Main Business Overview
13.14.5 Securetec Detektions-Systeme Latest Developments
13.15 Quest Diagnostics
13.15.1 Quest Diagnostics Company Information
13.15.2 Quest Diagnostics Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.15.3 Quest Diagnostics Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Quest Diagnostics Main Business Overview
13.15.5 Quest Diagnostics Latest Developments
13.16 Oranoxis
13.16.1 Oranoxis Company Information
13.16.2 Oranoxis Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.16.3 Oranoxis Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Oranoxis Main Business Overview
13.16.5 Oranoxis Latest Developments
13.17 Salimetrics
13.17.1 Salimetrics Company Information
13.17.2 Salimetrics Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.17.3 Salimetrics Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Salimetrics Main Business Overview
13.17.5 Salimetrics Latest Developments
13.18 Neogen Corporation
13.18.1 Neogen Corporation Company Information
13.18.2 Neogen Corporation Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.18.3 Neogen Corporation Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Neogen Corporation Main Business Overview
13.18.5 Neogen Corporation Latest Developments
13.19 UCP Biosciences
13.19.1 UCP Biosciences Company Information
13.19.2 UCP Biosciences Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.19.3 UCP Biosciences Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 UCP Biosciences Main Business Overview
13.19.5 UCP Biosciences Latest Developments
13.20 Lin-Zhi International
13.20.1 Lin-Zhi International Company Information
13.20.2 Lin-Zhi International Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.20.3 Lin-Zhi International Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Lin-Zhi International Main Business Overview
13.20.5 Lin-Zhi International Latest Developments
13.21 MEDACX
13.21.1 MEDACX Company Information
13.21.2 MEDACX Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.21.3 MEDACX Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 MEDACX Main Business Overview
13.21.5 MEDACX Latest Developments
13.22 MediNat
13.22.1 MediNat Company Information
13.22.2 MediNat Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.22.3 MediNat Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 MediNat Main Business Overview
13.22.5 MediNat Latest Developments
13.23 WHPM
13.23.1 WHPM Company Information
13.23.2 WHPM Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.23.3 WHPM Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 WHPM Main Business Overview
13.23.5 WHPM Latest Developments
13.24 AccuBioTech
13.24.1 AccuBioTech Company Information
13.24.2 AccuBioTech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.24.3 AccuBioTech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 AccuBioTech Main Business Overview
13.24.5 AccuBioTech Latest Developments
13.25 Assure Tech
13.25.1 Assure Tech Company Information
13.25.2 Assure Tech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.25.3 Assure Tech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 Assure Tech Main Business Overview
13.25.5 Assure Tech Latest Developments
13.26 Well Biotech
13.26.1 Well Biotech Company Information
13.26.2 Well Biotech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.26.3 Well Biotech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.26.4 Well Biotech Main Business Overview
13.26.5 Well Biotech Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

Oral fluid and saliva drug testing are methods used to detect the presence of drugs or their metabolites in a person's saliva. These tests are commonly used in various settings, including workplaces, law enforcement, and clinical environments, due to their non-invasive nature and ease of administration.
The global Oral Fluid and Saliva Drug Testing market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Oral Fluid and Saliva Drug Testing Industry Forecast” looks at past sales and reviews total world Oral Fluid and Saliva Drug Testing sales in 2023, providing a comprehensive analysis by region and market sector of projected Oral Fluid and Saliva Drug Testing sales for 2024 through 2030. With Oral Fluid and Saliva Drug Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Fluid and Saliva Drug Testing industry.
This Insight Report provides a comprehensive analysis of the global Oral Fluid and Saliva Drug Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Fluid and Saliva Drug Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oral Fluid and Saliva Drug Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Fluid and Saliva Drug Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Fluid and Saliva Drug Testing.
United States market for Oral Fluid and Saliva Drug Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Oral Fluid and Saliva Drug Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Oral Fluid and Saliva Drug Testing is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Oral Fluid and Saliva Drug Testing players cover Abbott, Premier Biotech, OraSure Technologies, MHE, VeriCheck, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Fluid and Saliva Drug Testing market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
5 Panels or Less
5 Panel-10 Panel
10 Panels or Above
Segmentation by Application:
Criminal Justice Testing
Workplace Testing
Rehabilitation Therapy
Sports Competition
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Premier Biotech
OraSure Technologies
MHE
VeriCheck
ulti med Products (Deutschland)
Healgen Scientific
Alcolizer
CareHealth America
AlphaBiolabs
AlcoDigital
Azova
Draeger
Securetec Detektions-Systeme
Quest Diagnostics
Oranoxis
Salimetrics
Neogen Corporation
UCP Biosciences
Lin-Zhi International
MEDACX
MediNat
WHPM
AccuBioTech
Assure Tech
Well Biotech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Oral Fluid and Saliva Drug Testing market?
What factors are driving Oral Fluid and Saliva Drug Testing market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Oral Fluid and Saliva Drug Testing market opportunities vary by end market size?
How does Oral Fluid and Saliva Drug Testing break out by Type, by Application?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Oral Fluid and Saliva Drug Testing by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Oral Fluid and Saliva Drug Testing by Country/Region, 2019, 2023 & 2030
2.2 Oral Fluid and Saliva Drug Testing Segment by Type
2.2.1 5 Panels or Less
2.2.2 5 Panel-10 Panel
2.2.3 10 Panels or Above
2.3 Oral Fluid and Saliva Drug Testing Sales by Type
2.3.1 Global Oral Fluid and Saliva Drug Testing Sales Market Share by Type (2019-2024)
2.3.2 Global Oral Fluid and Saliva Drug Testing Revenue and Market Share by Type (2019-2024)
2.3.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Type (2019-2024)
2.4 Oral Fluid and Saliva Drug Testing Segment by Application
2.4.1 Criminal Justice Testing
2.4.2 Workplace Testing
2.4.3 Rehabilitation Therapy
2.4.4 Sports Competition
2.4.5 Others
2.5 Oral Fluid and Saliva Drug Testing Sales by Application
2.5.1 Global Oral Fluid and Saliva Drug Testing Sale Market Share by Application (2019-2024)
2.5.2 Global Oral Fluid and Saliva Drug Testing Revenue and Market Share by Application (2019-2024)
2.5.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Application (2019-2024)
3 Global by Company
3.1 Global Oral Fluid and Saliva Drug Testing Breakdown Data by Company
3.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Company (2019-2024)
3.1.2 Global Oral Fluid and Saliva Drug Testing Sales Market Share by Company (2019-2024)
3.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Company (2019-2024)
3.2.1 Global Oral Fluid and Saliva Drug Testing Revenue by Company (2019-2024)
3.2.2 Global Oral Fluid and Saliva Drug Testing Revenue Market Share by Company (2019-2024)
3.3 Global Oral Fluid and Saliva Drug Testing Sale Price by Company
3.4 Key Manufacturers Oral Fluid and Saliva Drug Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Fluid and Saliva Drug Testing Product Location Distribution
3.4.2 Players Oral Fluid and Saliva Drug Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Oral Fluid and Saliva Drug Testing by Geographic Region
4.1 World Historic Oral Fluid and Saliva Drug Testing Market Size by Geographic Region (2019-2024)
4.1.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Oral Fluid and Saliva Drug Testing Market Size by Country/Region (2019-2024)
4.2.1 Global Oral Fluid and Saliva Drug Testing Annual Sales by Country/Region (2019-2024)
4.2.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Oral Fluid and Saliva Drug Testing Sales Growth
4.4 APAC Oral Fluid and Saliva Drug Testing Sales Growth
4.5 Europe Oral Fluid and Saliva Drug Testing Sales Growth
4.6 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales Growth
5 Americas
5.1 Americas Oral Fluid and Saliva Drug Testing Sales by Country
5.1.1 Americas Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024)
5.1.2 Americas Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024)
5.2 Americas Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024)
5.3 Americas Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Fluid and Saliva Drug Testing Sales by Region
6.1.1 APAC Oral Fluid and Saliva Drug Testing Sales by Region (2019-2024)
6.1.2 APAC Oral Fluid and Saliva Drug Testing Revenue by Region (2019-2024)
6.2 APAC Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024)
6.3 APAC Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Fluid and Saliva Drug Testing by Country
7.1.1 Europe Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024)
7.1.2 Europe Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024)
7.2 Europe Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024)
7.3 Europe Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Fluid and Saliva Drug Testing by Country
8.1.1 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Country (2019-2024)
8.1.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Revenue by Country (2019-2024)
8.2 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Type (2019-2024)
8.3 Middle East & Africa Oral Fluid and Saliva Drug Testing Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Fluid and Saliva Drug Testing
10.3 Manufacturing Process Analysis of Oral Fluid and Saliva Drug Testing
10.4 Industry Chain Structure of Oral Fluid and Saliva Drug Testing
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Fluid and Saliva Drug Testing Distributors
11.3 Oral Fluid and Saliva Drug Testing Customer
12 World Forecast Review for Oral Fluid and Saliva Drug Testing by Geographic Region
12.1 Global Oral Fluid and Saliva Drug Testing Market Size Forecast by Region
12.1.1 Global Oral Fluid and Saliva Drug Testing Forecast by Region (2025-2030)
12.1.2 Global Oral Fluid and Saliva Drug Testing Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Oral Fluid and Saliva Drug Testing Forecast by Type (2025-2030)
12.7 Global Oral Fluid and Saliva Drug Testing Forecast by Application (2025-2030)
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.1.3 Abbott Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Premier Biotech
13.2.1 Premier Biotech Company Information
13.2.2 Premier Biotech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.2.3 Premier Biotech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Premier Biotech Main Business Overview
13.2.5 Premier Biotech Latest Developments
13.3 OraSure Technologies
13.3.1 OraSure Technologies Company Information
13.3.2 OraSure Technologies Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.3.3 OraSure Technologies Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 OraSure Technologies Main Business Overview
13.3.5 OraSure Technologies Latest Developments
13.4 MHE
13.4.1 MHE Company Information
13.4.2 MHE Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.4.3 MHE Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 MHE Main Business Overview
13.4.5 MHE Latest Developments
13.5 VeriCheck
13.5.1 VeriCheck Company Information
13.5.2 VeriCheck Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.5.3 VeriCheck Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 VeriCheck Main Business Overview
13.5.5 VeriCheck Latest Developments
13.6 ulti med Products (Deutschland)
13.6.1 ulti med Products (Deutschland) Company Information
13.6.2 ulti med Products (Deutschland) Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.6.3 ulti med Products (Deutschland) Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 ulti med Products (Deutschland) Main Business Overview
13.6.5 ulti med Products (Deutschland) Latest Developments
13.7 Healgen Scientific
13.7.1 Healgen Scientific Company Information
13.7.2 Healgen Scientific Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.7.3 Healgen Scientific Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Healgen Scientific Main Business Overview
13.7.5 Healgen Scientific Latest Developments
13.8 Alcolizer
13.8.1 Alcolizer Company Information
13.8.2 Alcolizer Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.8.3 Alcolizer Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Alcolizer Main Business Overview
13.8.5 Alcolizer Latest Developments
13.9 CareHealth America
13.9.1 CareHealth America Company Information
13.9.2 CareHealth America Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.9.3 CareHealth America Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 CareHealth America Main Business Overview
13.9.5 CareHealth America Latest Developments
13.10 AlphaBiolabs
13.10.1 AlphaBiolabs Company Information
13.10.2 AlphaBiolabs Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.10.3 AlphaBiolabs Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 AlphaBiolabs Main Business Overview
13.10.5 AlphaBiolabs Latest Developments
13.11 AlcoDigital
13.11.1 AlcoDigital Company Information
13.11.2 AlcoDigital Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.11.3 AlcoDigital Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 AlcoDigital Main Business Overview
13.11.5 AlcoDigital Latest Developments
13.12 Azova
13.12.1 Azova Company Information
13.12.2 Azova Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.12.3 Azova Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Azova Main Business Overview
13.12.5 Azova Latest Developments
13.13 Draeger
13.13.1 Draeger Company Information
13.13.2 Draeger Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.13.3 Draeger Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Draeger Main Business Overview
13.13.5 Draeger Latest Developments
13.14 Securetec Detektions-Systeme
13.14.1 Securetec Detektions-Systeme Company Information
13.14.2 Securetec Detektions-Systeme Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.14.3 Securetec Detektions-Systeme Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Securetec Detektions-Systeme Main Business Overview
13.14.5 Securetec Detektions-Systeme Latest Developments
13.15 Quest Diagnostics
13.15.1 Quest Diagnostics Company Information
13.15.2 Quest Diagnostics Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.15.3 Quest Diagnostics Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Quest Diagnostics Main Business Overview
13.15.5 Quest Diagnostics Latest Developments
13.16 Oranoxis
13.16.1 Oranoxis Company Information
13.16.2 Oranoxis Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.16.3 Oranoxis Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Oranoxis Main Business Overview
13.16.5 Oranoxis Latest Developments
13.17 Salimetrics
13.17.1 Salimetrics Company Information
13.17.2 Salimetrics Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.17.3 Salimetrics Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 Salimetrics Main Business Overview
13.17.5 Salimetrics Latest Developments
13.18 Neogen Corporation
13.18.1 Neogen Corporation Company Information
13.18.2 Neogen Corporation Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.18.3 Neogen Corporation Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Neogen Corporation Main Business Overview
13.18.5 Neogen Corporation Latest Developments
13.19 UCP Biosciences
13.19.1 UCP Biosciences Company Information
13.19.2 UCP Biosciences Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.19.3 UCP Biosciences Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 UCP Biosciences Main Business Overview
13.19.5 UCP Biosciences Latest Developments
13.20 Lin-Zhi International
13.20.1 Lin-Zhi International Company Information
13.20.2 Lin-Zhi International Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.20.3 Lin-Zhi International Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Lin-Zhi International Main Business Overview
13.20.5 Lin-Zhi International Latest Developments
13.21 MEDACX
13.21.1 MEDACX Company Information
13.21.2 MEDACX Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.21.3 MEDACX Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 MEDACX Main Business Overview
13.21.5 MEDACX Latest Developments
13.22 MediNat
13.22.1 MediNat Company Information
13.22.2 MediNat Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.22.3 MediNat Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 MediNat Main Business Overview
13.22.5 MediNat Latest Developments
13.23 WHPM
13.23.1 WHPM Company Information
13.23.2 WHPM Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.23.3 WHPM Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 WHPM Main Business Overview
13.23.5 WHPM Latest Developments
13.24 AccuBioTech
13.24.1 AccuBioTech Company Information
13.24.2 AccuBioTech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.24.3 AccuBioTech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 AccuBioTech Main Business Overview
13.24.5 AccuBioTech Latest Developments
13.25 Assure Tech
13.25.1 Assure Tech Company Information
13.25.2 Assure Tech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.25.3 Assure Tech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 Assure Tech Main Business Overview
13.25.5 Assure Tech Latest Developments
13.26 Well Biotech
13.26.1 Well Biotech Company Information
13.26.2 Well Biotech Oral Fluid and Saliva Drug Testing Product Portfolios and Specifications
13.26.3 Well Biotech Oral Fluid and Saliva Drug Testing Sales, Revenue, Price and Gross Margin (2019-2024)
13.26.4 Well Biotech Main Business Overview
13.26.5 Well Biotech Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

本レポートと同じKEY WORD(oral fluid)の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/18 10:27

154.74 円

162.88 円

199.42 円

ページTOPに戻る